|
End-of-day quote
Korea S.E.
2025-04-03
|
5-day change | 1st Jan Change | ||
| 5,250.00 KRW | -20.63% |
|
-.--% | - |
| 25-04-06 | Celestra Inc. Auditor Raises 'Going Concern' Doubt | CI |
| 25-03-17 | Clinomics Inc. announced that it has received KRW 5.5 billion in funding | CI |
| Market Cap | 13.41B 9.67M 8.29M 7.75M 7.1M 13.32M 926M 13.5M 91.6M 35.72M 465M 36.32M 35.53M 1.54B | P/E 2024 |
-0.4x | P/E 2025 | -1.14x |
|---|---|---|---|---|---|
| Enterprise Value | 17.19B 12.4M 10.63M 9.94M 9.1M 17.08M 1.19B 17.31M 117M 45.81M 596M 46.58M 45.56M 1.97B | EV / Sales 2024 |
5.8x | EV / Sales 2025 | 8.56x |
| Free-Float |
78.31% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | -20.63% |
| 3 years | 4,245 | 48,000 | |
| 5 years | 4,245 | 143,000 | |
| 10 years | 4,245 | 261,500 |
| Manager | Title | Age | Since |
|---|---|---|---|
Seo-Hyeon Baek
CEO | Chief Executive Officer | 30 | 2024-03-28 |
Jong-Bin Baek
AUD | Comptroller/Controller/Auditor | 47 | 2025-03-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Seo-Hyeon Baek
BRD | Director/Board Member | 30 | 2024-03-28 |
Hoo-Hyuk Hong
BRD | Director/Board Member | 42 | 2025-09-24 |
Young-Il Yoo
BRD | Director/Board Member | 41 | 2024-06-13 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 6/17/24 | Sell | Chief Executive Officer | 100,000 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -20.63% | -.--% | -.--% | -86.19% | 9.67M | ||
| +1.09% | +5.26% | +4.52% | +26.24% | 51.61B | ||
| -1.07% | +2.82% | +465.96% | +586.75% | 44.89B | ||
| +1.47% | +9.79% | +35.92% | +21.40% | 42.77B | ||
| +1.44% | +7.77% | +19.38% | +92.75% | 42.58B | ||
| -0.93% | -4.33% | +16.18% | +53.76% | 31.82B | ||
| +1.32% | +7.30% | +33.89% | +150.10% | 17.33B | ||
| -0.60% | +1.93% | - | - | 16.63B | ||
| +0.03% | +3.41% | +6.55% | +32.10% | 14.76B | ||
| +1.28% | +5.41% | +82.40% | +47.43% | 14.09B | ||
| Average | -1.66% | +0.61% | +73.87% | +102.70% | 27.65B | |
| Weighted average by Cap. | +0.48% | +4.72% | +99.57% | +146.29% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 8.5B 6.13M 5.25M 4.92M 4.5M 8.45M 587M 8.56M 58.09M 22.65M 295M 23.03M 22.53M 975M | 2.01B 1.45M 1.24M 1.16M 1.06M 1.99M 139M 2.02M 13.72M 5.35M 69.63M 5.44M 5.32M 230M |
| Net income | -46.92B -33.86M -29M -27.14M -24.84M -46.62M -3.24B -47.24M -321M -125M -1.63B -127M -124M -5.38B | -11.77B -8.49M -7.28M -6.81M -6.23M -11.69M -813M -11.85M -80.43M -31.37M -408M -31.89M -31.2M -1.35B |
| Net Debt | 29.34B 21.17M 18.13M 16.97M 15.53M 29.15M 2.03B 29.53M 200M 78.17M 1.02B 79.49M 77.76M 3.37B | 3.79B 2.73M 2.34M 2.19M 2M 3.76M 261M 3.81M 25.86M 10.09M 131M 10.26M 10.03M 434M |
Employees
48
- Stock Market
- Stocks
- A352770 Stock
Select your edition
All financial news and data tailored to specific country editions
















